The discovery of PPARγ as a target for TZDs prompted the screening of a cohort of subjects with severe insulin resistance for mutations in PPARγ. Through this analysis, two new heterozygous mutations in PPARγ, Pro467Leu, and Val290Met, were identified in three subjects [14]. Here, PPARG is linked to Insulin resistance.